BN Business News
添加企业 →
本文翻译正在准备中。在此之前,我们暂时显示英文原文。

能源与环境 · 2016/1/41 分钟阅读

Northwest Medical Isotopes, LLC

本地自动翻译 · 来源原始语言

摘要

The U.S. Nuclear Regulatory Commission (NRC) has determined that the second and final part of the application for a construction permit, submitted by Northwest Medical Isotopes, LLC (NWMI) is acceptable for docketing. NWMI proposes to build a medical radioisotope production facility located in Columbia, Missouri.

来源原始语言: Federal Register — Nuclear Regulatory Commission打开原始公告 →

探索专题

商业洞察 →